Recent trends in U.S. breast cancer incidence, survival, and mortality rates.

Trends in inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program at the National Cancer Institute. J Natl Cancer Inst (2005) 4.14

The changing global patterns of female breast cancer incidence and mortality. Breast Cancer Res (2004) 3.66

Nutrition and survival after the diagnosis of breast cancer: a review of the evidence. J Clin Oncol (2002) 3.16

Effects of multidisciplinary team working on breast cancer survival: retrospective, comparative, interventional cohort study of 13 722 women. BMJ (2012) 2.88

Contribution of chronic conditions to aggregate changes in old-age functioning. Am J Public Health (2000) 2.55

Measures of racial/ethnic health disparities in cancer mortality rates and the influence of socioeconomic status. J Natl Med Assoc (2007) 2.27

Screening Mammography Program of British Columbia: pattern of use and health care system costs. CMAJ (1999) 2.05

Complexities in the estimation of overdiagnosis in breast cancer screening. Br J Cancer (2008) 1.90

Decreased rates of advanced breast cancer due to mammography screening in The Netherlands. Br J Cancer (2004) 1.85

Gene expression profiling of peripheral blood cells for early detection of breast cancer. Breast Cancer Res (2010) 1.64

Metastatic breast cancer to the gastrointestinal tract: a case series and review of the literature. World J Gastroenterol (2006) 1.59

Advanced breast cancer incidence following population-based mammographic screening. Ann Oncol (2011) 1.53

Five years of tamoxifen--or more? J Natl Cancer Inst (1996) 1.53

The role of cancer registries in cancer control. Int J Clin Oncol (2008) 1.40

Using cultural beliefs and patterns to improve mammography utilization among African-American women: the Witness Project. J Natl Med Assoc (2000) 1.35

The multiplex bead array approach to identifying serum biomarkers associated with breast cancer. Breast Cancer Res (2009) 1.28

Temporal trends in geographic disparities in small-area breast cancer incidence and mortality, 1988 to 2005. Cancer Epidemiol Biomarkers Prev (2010) 1.06

Spatial association of racial/ethnic disparities between late-stage diagnosis and mortality for female breast cancer: where to intervene? Int J Health Geogr (2011) 1.06

Competing causes of death for women with breast cancer and change over time from 1975 to 2003. Am J Clin Oncol (2008) 1.03

Geographic variations in breast cancer mortality: do higher rates imply elevated incidence or poorer survival? Am J Public Health (1998) 0.99

The effects of age and emotional acceptance on distress among breast cancer patients. Support Care Cancer (2006) 0.94

Identifying risk factors for disparities in breast cancer mortality among African-American and Hispanic women. Womens Health Issues (2012) 0.92

Unique presentations of invasive lobular breast cancer: a case series. Int J Biomed Sci (2014) 0.91

The Evaluation of p53 Polymorphism at Codon 72 and Association With Breast Cancer in Iran: A Systematic Review and Meta-analysis. J Cancer Prev (2016) 0.89

Does architectural lighting contribute to breast cancer? J Carcinog (2006) 0.89

Recent trends in breast cancer incidence in Sweden. Br J Cancer (1998) 0.89

Trends in breast cancer stage and mortality in Michigan (1992-2009) by race, socioeconomic status, and area healthcare resources. PLoS One (2013) 0.87

Polycyclic aromatic hydrocarbon-DNA adducts and survival among women with breast cancer. Environ Res (2009) 0.86

Breast cancer mortality trends in two areas of the province of Florence, Italy, where screening programmes started in the 1970s and 1990s. Br J Cancer (2004) 0.85

Adherence to adjuvant endocrine therapy in estrogen receptor-positive breast cancer patients with regular follow-up. Can J Surg (2014) 0.84

Parallels between the development of therapeutic drugs and cancer health disparity programs: implications for Disparities Reduction. Cancer (2008) 0.84

Screening mammography for women aged 40-49: are we off the fence yet? CMAJ (2001) 0.83

The contribution of postmenopausal hormone use cessation to the declining incidence of breast cancer. Cancer Causes Control (2010) 0.83

Compliance and toxicity of adjuvant CMF in elderly breast cancer patients: a single-center experience. BMC Cancer (2005) 0.82

Life after breast cancer: dealing with lymphoedema. Clin Med Insights Oncol (2011) 0.82

Cognitive function in breast cancer survivors compared to healthy age- and education-matched women. Clin Neuropsychol (2009) 0.81

Racial differences in breast cancer, cardiovascular disease, and all-cause mortality among women with ductal carcinoma in situ of the breast. Breast Cancer Res Treat (2014) 0.80

Antiangiogenic tetrathiomolybdate protects against Her2/neu-induced breast carcinoma by hypoplastic remodeling of the mammary gland. Clin Cancer Res (2009) 0.80

Screening women at increased risk with MRI. Cancer Imaging (2005) 0.79

DDT and Breast Cancer Trends. Environ Health Perspect (2008) 0.77

Re: Recent trends in U.S. breast cancer incidence, survival, and mortality rates. J Natl Cancer Inst (1997) 0.77

Barriers to early presentation and diagnosis of breast cancer among African women living in sub-Saharan Africa. PLoS One (2017) 0.75

Gastrointestinal tract metastasis from tubulolobular carcinoma of the breast: a case report and review of the literature. Onco Targets Ther (2014) 0.75

Important Factors Affecting Adjuvant Treatment Decision in Stage IA Breast Cancer Patients in Turkey. Breast Care (Basel) (2014) 0.75

Dedicated screening mammography for diagnosis of small breast cancer. World J Surg (2004) 0.75

Potential for cancer related health services research using a linked Medicare-tumor registry database. Med Care (1993) 9.72

Breast Cancer Surveillance Consortium: a national mammography screening and outcomes database. AJR Am J Roentgenol (1997) 7.62

Residential exposure to magnetic fields and acute lymphoblastic leukemia in children. N Engl J Med (1997) 6.72

Breast cancer clusters in the northeast United States: a geographic analysis. Am J Epidemiol (1997) 5.73

Cellular-telephone use and brain tumors. N Engl J Med (2001) 5.57

The surveillance, epidemiology, and end results program: a national resource. Cancer Epidemiol Biomarkers Prev (1999) 5.49

Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older. JAMA (2001) 5.28

The annual report to the nation on the status of cancer, 1973-1997, with a special section on colorectal cancer. Cancer (2000) 4.89

Prostate cancer and supplementation with alpha-tocopherol and beta-carotene: incidence and mortality in a controlled trial. J Natl Cancer Inst (1998) 4.72

Evaluating cluster alarms: a space-time scan statistic and brain cancer in Los Alamos, New Mexico. Am J Public Health (1998) 4.71

Trends in reported incidence of primary malignant brain tumors in children in the United States. J Natl Cancer Inst (1998) 4.32

Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends. J Natl Cancer Inst (2001) 4.26

The brief MAST: a shortened version of the Michigan Alcoholism Screening Test. Am J Psychiatry (1972) 4.12

The role of increasing detection in the rising incidence of prostate cancer. JAMA (1995) 3.79

Completeness of hospital cancer case reporting from the SEER Program of the National Cancer Institute. Cancer (1995) 3.78

Cervical cancer screening: who is not screened and why? Am J Public Health (1991) 3.70

Utilization of health and mental health services. Three Epidemiologic Catchment Area sites. Arch Gen Psychiatry (1984) 3.55

Frequent clones of p53-mutated keratinocytes in normal human skin. Proc Natl Acad Sci U S A (1996) 3.38

Cancer surveillance series: interpreting trends in prostate cancer--part I: Evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates. J Natl Cancer Inst (1999) 3.35

Second cancers after adjuvant tamoxifen therapy for breast cancer. J Natl Cancer Inst (1996) 3.26

Cancer surveillance series [corrected]: brain and other central nervous system cancers: recent trends in incidence and mortality. J Natl Cancer Inst (1999) 3.25

Annual report to the nation on the status of cancer, 1973-1996, with a special section on lung cancer and tobacco smoking. J Natl Cancer Inst (1999) 3.19

Cancer incidence after retinoblastoma. Radiation dose and sarcoma risk. JAMA (1997) 3.00

Is the supply of mammography machines outstripping need and demand? An economic analysis. Ann Intern Med (1990) 2.99

Alpha-Tocopherol and beta-carotene supplements and lung cancer incidence in the alpha-tocopherol, beta-carotene cancer prevention study: effects of base-line characteristics and study compliance. J Natl Cancer Inst (1996) 2.98

Comorbidity and age as predictors of risk for early mortality of male and female colon carcinoma patients: a population-based study. Cancer (1998) 2.94

Factors associated with surgical and radiation therapy for early stage breast cancer in older women. J Natl Cancer Inst (1996) 2.91

Rates of symptoms of depression in a national sample. Am J Epidemiol (1981) 2.77

Recent cancer trends in the United States. J Natl Cancer Inst (1995) 2.76

Breast cancer among black and white women in the 1980s. Changing patterns in the United States by race, age, and extent of disease. Cancer (1993) 2.70

Aging and cancer in America. Demographic and epidemiologic perspectives. Hematol Oncol Clin North Am (2000) 2.58

Medicare payments from diagnosis to death for elderly cancer patients by stage at diagnosis. Med Care (1995) 2.55

Site-specific cleavage of DNA at 8- and 10-base-pair sequences. Proc Natl Acad Sci U S A (1984) 2.48

Cancer incidence and mortality, 1973-1995: a report card for the U.S. Cancer (1998) 2.48

Cancer surveillance series: interpreting trends in prostate cancer--part II: Cause of death misclassification and the recent rise and fall in prostate cancer mortality. J Natl Cancer Inst (1999) 2.48

Analysis of breast cancer mortality and stage distribution by age for the Health Insurance Plan clinical trial. J Natl Cancer Inst (1988) 2.47

Cancer surveillance series: recent trends in childhood cancer incidence and mortality in the United States. J Natl Cancer Inst (1999) 2.38

Case-control study of canine malignant lymphoma: positive association with dog owner's use of 2,4-dichlorophenoxyacetic acid herbicides. J Natl Cancer Inst (1991) 2.36

Cancer surveillance series: interpreting trends in prostate cancer--part III: Quantifying the link between population prostate-specific antigen testing and recent declines in prostate cancer mortality. J Natl Cancer Inst (1999) 2.35

Association between childhood acute lymphoblastic leukemia and use of electrical appliances during pregnancy and childhood. Epidemiology (1998) 2.33

Temporal patterns in colorectal cancer incidence, survival, and mortality from 1950 through 1990. J Natl Cancer Inst (1994) 2.31

The oxidative DNA lesion 8,5'-(S)-cyclo-2'-deoxyadenosine is repaired by the nucleotide excision repair pathway and blocks gene expression in mammalian cells. J Biol Chem (2000) 2.28

Effects of alpha-tocopherol and beta-carotene supplements on cancer incidence in the Alpha-Tocopherol Beta-Carotene Cancer Prevention Study. Am J Clin Nutr (1995) 2.25

Evolutionary conservation and somatic mutation hotspot maps of p53: correlation with p53 protein structural and functional features. Oncogene (1999) 2.19

Cancer statistics by race and ethnicity. CA Cancer J Clin (1998) 2.18

Long-term therapy with low-dose isotretinoin for prevention of basal cell carcinoma: a multicenter clinical trial. Isotretinoin-Basal Cell Carcinoma Study Group. J Natl Cancer Inst (1992) 2.15

The usefulness of screening for mental illness. Lancet (1984) 2.12

Prevention of skin cancer in xeroderma pigmentosum with the use of oral isotretinoin. N Engl J Med (1988) 2.03

Staging laparotomy in early ovarian cancer. JAMA (1983) 2.02

Human papillomavirus types 52 and 58 are prevalent in cervical cancers from Chinese women. Int J Cancer (1997) 2.00

Increased hypermutation at G and C nucleotides in immunoglobulin variable genes from mice deficient in the MSH2 mismatch repair protein. J Exp Med (1998) 2.00

Recent incidence trends for breast cancer in women and the relevance of early detection: an update. CA Cancer J Clin (1993) 1.94

Breast cancer trends of black women compared with white women. Arch Fam Med (1999) 1.91

Black-white differences in cancer prevention knowledge and behavior. Am J Public Health (1991) 1.91

The relative survival rate. Cancer (1995) 1.89

A longitudinal study of offset in the use of nonpsychiatric services following specialized mental health care. Med Care (1983) 1.87

Altered spectra of hypermutation in antibodies from mice deficient for the DNA mismatch repair protein PMS2. Proc Natl Acad Sci U S A (1998) 1.86

Long-term cancer patient survival in the United States. Cancer Epidemiol Biomarkers Prev (1998) 1.83

Are children living near high-voltage power lines at increased risk of acute lymphoblastic leukemia? Am J Epidemiol (2000) 1.82

Household solvent exposures and childhood acute lymphoblastic leukemia. Am J Public Health (2001) 1.80

Psychosocial and physical outcomes of primary breast cancer therapy: mastectomy vs excisional biopsy and irradiation. Breast Cancer Res Treat (1983) 1.80

Estimating the treatment costs of breast and lung cancer. Med Care (1991) 1.80

Second cancers in patients with chronic lymphocytic leukemia. J Natl Cancer Inst (1992) 1.79

The design of the Epidemiologic Catchment Area surveys. The control and measurement of error. Arch Gen Psychiatry (1984) 1.79

Evidence that childhood acute lymphoblastic leukemia is associated with an infectious agent linked to hygiene conditions. Cancer Causes Control (1998) 1.78

Screening mammography in community practice: positive predictive value of abnormal findings and yield of follow-up diagnostic procedures. AJR Am J Roentgenol (1995) 1.78

Cigarette smoking among U.S. adults by state and region: estimates from the current population survey. J Natl Cancer Inst (1996) 1.78

Differences between black and white women with breast cancer in time from symptom recognition to medical consultation. Black/White Cancer Survival Study Group. J Natl Cancer Inst (1992) 1.77

On the estimation of survival. Semin Surg Oncol (1994) 1.76

Effects of supplemental alpha-tocopherol and beta-carotene on colorectal cancer: results from a controlled trial (Finland) Cancer Causes Control (2000) 1.75

Recent trends in lung cancer mortality in the United States. J Natl Cancer Inst (2001) 1.72

The Maine Women's Health Study: I. Outcomes of hysterectomy. Obstet Gynecol (1994) 1.72

Study design in the evaluation of breast cancer imaging technologies. Acad Radiol (2000) 1.71

Association of atypical characteristics of benign breast lesions with subsequent risk of breast cancer. Cancer (1972) 1.70

G2 chromosomal radiosensitivity of ataxia-telangiectasia heterozygotes. Cancer Genet Cytogenet (1985) 1.67

Detection of staphylococcal enterotoxins A, B, C, D, and E in foods by radioimnunoassay, using staphyloccal cells containing protein A as immunoadsorbent. Appl Environ Microbiol (1978) 1.67

Americans' knowledge of cancer risk and survival. Prev Med (1997) 1.63

Falling rates of lung cancer in men in the United States. Lancet (1986) 1.62

Conditional survival estimates in 34,963 patients with invasive carcinoma of the colon. Dis Colon Rectum (1998) 1.61

Statistical issues in interpretation of chronic bioassay tests for carcinogenicity. J Natl Cancer Inst (1979) 1.60

A method for partitioning cancer mortality trends by factors associated with diagnosis: an application to female breast cancer. J Clin Epidemiol (1994) 1.57

The Maine Women's Health Study: II. Outcomes of nonsurgical management of leiomyomas, abnormal bleeding, and chronic pelvic pain. Obstet Gynecol (1994) 1.56

Effect of changes in cancer classification and the accuracy of cancer death certificates on trends in cancer mortality. Ann N Y Acad Sci (1990) 1.56

Report of an outbreak: nursing home architecture and influenza-A attack rates. J Am Geriatr Soc (1996) 1.55

Frequency distributions of breast cancer characteristics classified by estrogen receptor and progesterone receptor status for eight racial/ethnic groups. Cancer (2001) 1.52

Second primary cancer after treatment for cervical cancer. An international cancer registries study. Cancer (1995) 1.52

A single nucleotide polymorphism in the 5' untranslated region of RAD51 and risk of cancer among BRCA1/2 mutation carriers. Cancer Epidemiol Biomarkers Prev (2001) 1.51

Psychiatric disorders in primary care. Results of a follow-up study. Arch Gen Psychiatry (1985) 1.51